Lupin Pharmaceuticals, Inc.
GPTKB entity
Properties (43)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Merck_KGaA's_biosimilars_business
gptkb:Gavis_Pharmaceuticals |
gptkbp:employees |
Over 20,000
|
gptkbp:founded |
1968
|
gptkbp:founder |
gptkb:Desh_Bandhu_Gupta
|
gptkbp:headquarters |
gptkb:Mumbai,_India
|
https://www.w3.org/2000/01/rdf-schema#label |
Lupin Pharmaceuticals, Inc.
|
gptkbp:market |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Africa Europe |
gptkbp:operates_in |
Global Market
|
gptkbp:partnerships |
gptkb:Eli_Lilly
gptkb:GSK gptkb:AstraZeneca gptkb:Mylan gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Baxter_International gptkb:Pfizer gptkb:Teva_Pharmaceuticals gptkb:Roche gptkb:Baxter_Healthcare Novartis Sanofi AbbVie |
gptkbp:products |
Branded Drugs
Generic_Drugs |
gptkbp:research_areas |
Cardiology
Oncology Urology Diabetes Gynecology Infectious Diseases Pediatrics Dermatology Respiratory CNS |
gptkbp:revenue |
$2.1 billion (2021)
|
gptkbp:subsidiary |
gptkb:Lupin_Limited
|
gptkbp:website |
www.lupin.com
|